All Stories

  1. New Derivatives of Caracasine Acid with Anti-Leukemic Activity and Limited Effectiveness in Spheroid Cultures
  2. Food-Specific IgG Antibodies: Decoding Their Dual Role in Immune Tolerance and Food Intolerance
  3. The response of the Venezuelan population to the sinopharm vaccine
  4. Endometriosis: An Immunologist’s Perspective
  5. Specialized Pro-Resolving Lipid Mediators in Pulmonary Diseases: Molecular and Therapeutic Implications
  6. Identification of a novel Azaspirooxindolinone-based PROTAC for selective BTK degradation and enhanced anticancer activity
  7. Diethyldithiocarbamate-copper complex ignites the tumor microenvironment through NKG2D-NKG2DL axis
  8. Colchicine for the primary prevention of cardiovascular events
  9. Exploring the Immunological Aspects and Treatments of Recurrent Pregnancy Loss and Recurrent Implantation Failure
  10. Exploring How Adipose Tissue, Obesity, and Gender Influence the Immune Response to Vaccines: A Comprehensive Narrative Review
  11. Correction: De Sanctis et al. Lck Function and Modulation: Immune Cytotoxic Response and Tumor Treatment More Than a Simple Event. Cancers 2024, 16, 2630
  12. Polymer nanotherapeutics with the controlled release of acetylsalicylic acid and its derivatives inhibiting cyclooxygenase isoforms and reducing the production of pro-inflammatory mediators
  13. Exploring the Contrasts and Similarities of Dengue and SARS-CoV-2 Infections During the COVID-19 Era
  14. IgG Antibody Titers Against Ascaris lumbricoides, Strongyloides stercolaris, and Toxocara canis in Venezuelan Patients with Asthma or COPD
  15. PERFIL INMUNOLÓGICO EN INDIVIDUOS ADULTOS VENEZOLANOS CON INFECCIÓN AGUDA POR SARS–CoV-2
  16. Unlocking the Puzzle: Investigating the Role of Interleukin 17 Genetic Polymorphisms, Circulating Lymphocytes, and Serum Levels in Venezuelan Women with Recurrent Pregnancy Loss
  17. Interleukin-receptor antagonist and tumour necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases
  18. Microbiota and Recurrent Pregnancy Loss (RPL); More than a Simple Connection
  19. Role of Micronutrients in the Response to SARS-CoV-2 Infection in Pediatric Patients
  20. Lck Function and Modulation: Immune Cytotoxic Response and Tumor Treatment More Than a Simple Event
  21. ESTUDIO PILOTO DEL EFECTO DEL TIPO Y CONSERVACION DE LA MUESTRA Y MÉTODO, EN LA MEDICION DE LA CONCENTRACION DE LAS FRACCIONES C3 Y C4 DEL COMPLEMENTO.
  22. Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond
  23. Genetic polymorphism in primary, recurrent pregnancy loss
  24. Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies
  25. Isoform-Directed Control of c-Myc Functions: Understanding the Balance from Proliferation to Growth Arrest
  26. Synthesis, Antimalarial, Antileishmanial, and Cytotoxicity Activities and Preliminary In Silico ADMET Studies of 2-(7-Chloroquinolin-4-ylamino)ethyl Benzoate Derivatives
  27. CRISPR/Cas9 bioluminescence-based assay for monitoring CFTR trafficking to the plasma membrane
  28. A Synopsis of Hepatitis C Virus Treatments and Future Perspectives
  29. SARS-CoV-2 Infection in Venezuelan Pediatric Patients—A Single Center Prospective Observational Study
  30. Autoimmunity and Immunodeficiency in Severe SARS-CoV-2 Infection and Prolonged COVID-19
  31. Novel 7-Chloro-(4-thioalkylquinoline) Derivatives: Synthesis and Antiproliferative Activity through Inducing Apoptosis and DNA/RNA Damage
  32. Innate Immune Response in Hypertension
  33. Synthesis, Leishmanicidal, Trypanocidal, Antiproliferative Assay and Apoptotic Induction of (2-Phenoxypyridin-3-yl)naphthalene-1(2H)-one Derivatives
  34. Effect of tetrahydroquinoline derivatives on the intracellular Ca2+ homeostasis in breast cancer cells (MCF-7) and its relationship with apoptosis.
  35. Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches
  36. Molecular Mechanisms of Chloroquine and Hydroxychloroquine use in Cancer Therapy
  37. Caracasine, an ent-kaurane diterpene with proapoptotic and pro-differentiator activity in human leukaemia cell lines
  38. Cellular Senescence: Molecular Targets, Biomarkers, and Senolytic Drugs
  39. Estudio piloto: análisis y detección de anticuerpos IgM e IgG específicos contra el dominio de unión al receptor de la proteína de la espiga del SARS-CoV-2
  40. Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis
  41. One-Step Synthesis of Nanoliposomal Copper Diethyldithiocarbamate and Its Assessment for Cancer Therapy
  42. Effect of Glucocorticosteroids in Diamond-Blackfan Anaemia: Maybe Not as Elusive as It Seems
  43. Overview of Memory NK Cells in Viral Infections: Possible Role in SARS-CoV-2 Infection
  44. Kauranes as Anti-inflammatory and Immunomodulatory Agents: An Overview of In Vitro and In Vivo Effects
  45. The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises
  46. Assessment of Inflammatory Response and its Resolution in Viral Infection and Rheumatoid Arthritis
  47. Potential Role of Bioactive Lipids in Rheumatoid Arthritis
  48. Importancia de la respuesta inmune celular adaptativa en la infección por SARS-CoV-2
  49. Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?
  50. Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies
  51. A Brief Analysis of Tissue-Resident NK Cells in Pregnancy and Endometrial Diseases: The Importance of Pharmacologic Modulation
  52. Editorial: Quo Vadis Lipid Mediators – Lipid Mediators Implication in Inflammation and Chronic Inflammatory Diseases
  53. Coronavirus infection: An immunologists' perspective
  54. Synthesis and antimalarial and anticancer evaluation of 7‐chlorquinoline‐4‐thiazoleacetic derivatives containing aryl hydrazide moieties
  55. POTENCIALES OPCIONES TERAPÉUTICAS PARA INFECCIONES POR SARS-CoV 1 Y 2
  56. CFTR Correctors and Antioxidants Partially Normalize Lipid Imbalance but not Abnormal Basal Inflammatory Cytokine Profile in CF Bronchial Epithelial Cells
  57. Quo Vadis Lipid Mediators – Lipid Mediators Implication in Inflammation and Chronic Inflammatory Diseases
  58. Subpoblaciones linfocitarias de pacientes venezolanos infectados con SARS-CoV-2
  59. Importance of miRNA in SARS-CoV2 infection
  60. Functionally Relevant Differences in Plasma Fatty Acid Composition and Expression of Cytotoxic and Inhibitory NK Cell Receptors between Healthy Young and Healthy Elder Adults
  61. Small Natural and Synthetic Molecules for Therapeutic Use
  62. A brief overview of cancer research in the elderly population
  63. The role of essential fatty acids in cystic fibrosis and normalizing effect of fenretinide
  64. Age-Dependent Progression in Lung Pathophysiology can be Prevented by Restoring Fatty Acid and Ceramide Imbalance in Cystic Fibrosis
  65. Treatment of allergic asthma with Fenretinide formulation (LAU-7b) downregulates Ormdl3 expression and normalizes ceramides imbalance
  66. Fenretinide favorably affects mucins (MUC5AC/MUC5B) and fatty acid imbalance in a manner mimicking CFTR-induced correction
  67. Synthesis and biological activity of 2-[2-(7-chloroquinolin-4-ylthio)-4-methylthiazol-5-yl]-N-phenylacetamide derivatives as antimalarial and cytotoxic agents
  68. Effect of fenretidine on murine asthma model
  69. Pharmacologic Modulation of the Immune Response Against Tumours in the Elderly
  70. New structures as anti malarials and anti cancer drugs
  71. Caracasine acid is a seco kaurene purified from Croton caracasana
  72. Reviw on the importance of long chain fatty acids
  73. Effects of flavonoids and Its Derivatives on Immune Cell Responses
  74. Synthesis, antimalarial, antiproliferative, and apoptotic activities of benzimidazole-5-carboxamide derivatives
  75. Cardiorespiratory responses, nitric oxide production and inflammatory factors in patients with myocardial infarction after rehabilitation
  76. Importance of zona pellucida binding protgein in inflammation
  77. Anti malarial and anti cancer compound
  78. Fenretinide differentially modulates the levels of long- and very long-chain ceramides by downregulating Cers5 enzyme: evidence from bench to bedside
  79. Proteomic profiling reveals DNA damage, nucleolar and ribosomal stress are the main responses to oxaliplatin treatment in cancer cells
  80. A Review of Clinical Trials of Belimumab in the Management of Systemic Lupus Erythematosus
  81. Editorial of immunomodulation issue
  82. Correction of lung inflammation in a F508del CFTR murine cystic fibrosis model by the sphingosine-1-phosphate lyase inhibitor LX2931
  83. Sphingosine inhibits the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) activity
  84. Inflammatory gene polymorphisms in asthma and chronic obstructive pulmonary disease in Venezuela
  85. Peptide Vaccines for Cancer Therapy
  86. Editorial (Thematic Issue: Vaccines)
  87. Vaccine Therapy Update for Pregnant, Immunocompromised, and Chronic Diseases Patients
  88. Lycopene improves the distorted ratio between AA/DHA in the seminal plasma of infertile males and increases the likelihood of successful pregnancy
  89. New treatment for asthma
  90. An Overview of Hepatitis C Vaccines
  91. This review refers to the different approaches for vaccine therapy in HIV infection
  92. Importance in unsaturated fatty acids in zoonotic infection
  93. Candidate Markers Associated with the Probability of Future Pulmonary Exacerbations in Cystic Fibrosis Patients
  94. Metabolic Syndrome and Asthma
  95. Surfactant Protein D in Chornic Obstructive Pulmonary Disease (COPD)
  96. Fenretinide Corrects the Imbalance between Omega-6 to Omega-3 Polyunsaturated Fatty Acids and Inhibits Macrophage Inflammatory Mediators via the ERK Pathway
  97. The review focus on the different adjuvants and delivery systems used for diffetent vaccines
  98. Recent Patents in Autophagy and Immune Response
  99. Nitric oxide synthase and its relation to PKC activation
  100. Gene-Metabolite Expression in Blood Can Discriminate Allergen-Induced Isolated Early from Dual Asthmatic Responses
  101. Effect of lycopene administration in cystic fibrosis patients
  102. Biomarkers in Asthma and COPD
  103. Lipid profile analysis in spinal trauma patients shows severe distortion of AA/DHA after injury
  104. Beta 2 adrenergic receptor polymorphisms, at codons 16 and 27, and bronchodilator responses in adult venezuelan asthmatic patients
  105. Cytotoxic effects of fisturalin-3 and 11-deoxyfisturalin-3 on jurkat and u937 cell lines
  106. Perspectives of New Therapies for Endometriosis
  107. 336 The Leukotriene C4 Synthase (A-444C) Promoter Polymorphism in Venezuelan Individuals with Asthma
  108. Role of Beta2 Agonists in Respiratory Medicine with Particular Attention to Novel Patents and Effects on Endocrine System and Immune Response
  109. Inhibitors of Phosphoinositol 3 Kinase and NFκB for the Treatment of Chronic Obstructive Pulmonary Disease
  110. The marine sponge toxin agelasine B increases the intracellular Ca2+ concentration and induces apoptosis in human breast cancer cells (MCF-7)
  111. New pharmacological treatments for patients with chronic obstructive pumonary disease (copd)
  112. Specific activation of human neutrophils by scorpion venom: A flow cytometry assessment
  113. Atherosclerosis risk in SLE is not dependent on macrophage uptake of ox-LDL
  114. Ceramide in Cystic Fibrosis: A Potential New Target for Therapeutic Intervention
  115. Pharmacological Properties of Thalidomide and its Analogues
  116. Fenretinide Promotes Functional Recovery and Tissue Protection after Spinal Cord Contusion Injury in Mice
  117. CD16 cross-linking induces increased expression of CD56 and production of IL-12 in peripheral NK cells
  118. Increased lipid peroxidation and abnormal fatty acid profiles in seminal and blood plasma of normozoospermic males from infertile couples
  119. Cystic Fibrosis Fatty Acid Imbalance Is Linked to Ceramide Deficiency and Corrected by Fenretinide
  120. Pharmacological Modulation of Th17
  121. Serum adipokine levels in patients with systemic lupus erythematosus
  122. Total and biologically active CD154 in patients with SLE
  123. Decreased transcription, expression and function of low-density lipoprotein receptor in leukocytes from patients with systemic lupus erythematosus
  124. Fenretinide prevents the development of osteoporosis in Cftr-KO mice
  125. Abnalysis of the effect of smoking in muscle
  126. Possible role of NFĸB in the embryonic vascular remodeling and the endothelial-mesenchymal transition process
  127. Fenretinide Corrects Newly Found Ceramide Deficiency in Cystic Fibrosis
  128. Nitric Oxide Metabolites and Nitrotyrosine in Asthma and COPD
  129. Toll-Like Receptors, Cytokines and the Immunotherapeutics of Asthma
  130. New Frontiers in the Therapeutic Management of Transplant Rejection
  131. Role of SLC11A1 (formerly NRAMP1) in regulation of signal transduction induced by Toll-like receptor 7 ligands
  132. F.23. Polymorphisms of Toll-Like Receptor 2 and 4 Genes in Asthma and COPD
  133. Skeletal muscle inflammation and nitric oxide in patients with COPD
  134. Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients
  135. Interaction of immune complexes isolated from hepatitis C virus-infected individuals with human cell lines
  136. Lipoprotein lipase protects bovine endothelial cells from human NK cytotoxic activity
  137. Expression of CD40/CD40L is important is chicken embryo aorta transdifferentiation
  138. Leptin and leptin receptors during malaria infection in mice
  139. Activity profile in multiple sclerosis: an integrative approach A preliminary report
  140. Expression of surface molecules on eosinophils from patients with persistent allergic rhinitis (PAR), before and after treatment
  141. Clearance of Infection with Mycobacterium bovis BCG in Mice Is Enhanced by Treatment with S28463 (R-848), and Its Efficiency Depends on Expression of Wild-Type Nramp1 (Resistance Allele)
  142. Antihypertensive Treatment Decreased Serum Leptin Levels in Severe Preeclampsia during Pregnancy
  143. Endothelial Cells Scraped from the Luminal Surface of Bovine Pulmonary Artery Give Rise to Nonmuscle Cells
  144. Increased Peroxide Production by Polymorphonuclear Cells of Chronic Hepatitis C Virus-Infected Patients
  145. Expression of low‐density lipoprotein receptors in peripheral blood and tonsil B lymphocytes
  146. Characterization of Local Memory Cells in Stage‐Classified Pulmonary Tuberculosis: Preliminary Observations
  147. Phenotypic difference between Bcgr and Bcgs macrophages is related to differences in protein-kinase-C-dependent signalling
  148. Nitric Oxide in Different Types of Hypertension during Pregnancy
  149. Impaired NK cytotoxicity of NK cells of HCV patients
  150. Secretion of cytokines by natural killer cells primed with interleukin‐2 and stimulated with different lipoproteins
  151. Low density lipoprotein receptor expression and function in human polymorphonuclear leucocytes
  152. Expression and Function of Low-Density Lipoprotein Receptors in CD3−CD16+CD56+Cells: Effect of Interleukin 2
  153. Effects of Different Lipoproteins on the Proliferative Response of Interleukin-2-Activated T Lymphocytes and Large Granular Lymphocytes
  154. Dietary n-3 polyunsaturated fatty acids prevent the development of atherosclerotic lesions in mice. Modulation of macrophage secretory activities
  155. High macrophage lipoprotein lipase expression and secretion are associated in inbred murine strains with susceptibility to atherosclerosis
  156. Kinetics of product inhibition and mechanisms of lipoprotein lipase activation by apolipoprotein C-II
  157. The kinetics of heparin inhibition of the esterase and basal lipase activities of lipoprotein lipase
  158. The effects of bovine serum albumin and oleic acid on rat pancreatic lipase and bovine milk lipoprotein lipase